Nexus Pharmaceuticals has announced an agreement with the village of Pleasant Prairie, Wisconsin to build an industry-leading sterile injectable manufacturing facility. The multi-phase, multi-year project is expected to be completed in ten years, with an estimated investment of $250 million. Construction is planned to commence in August 2019 and is expected to be completed in 2021. The initial phase 1 investment of $85 million will support a new, 100,000 square foot three-story manufacturing facility. The facility is being designed by Integrated Project Services (IPS) with construction management services being provided by Turner Construction. Learn More